Scheme 1.
Schematic illustration of (A) the construction of the biomimetic “Gemini nanoimmunoregulators” and (B) the synergistic photoimmunotherapy via spatiotemporal targeted PTT, phenotype reversion of TAMs, and PD-L1 inhibition.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.